• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?

作者信息

Chua Brandon Wen Bing, Ma Viva Yan, Alcántar-Fernández Jonathan, Wee Hwee Lin

机构信息

Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.

Health Economics and Outcomes Research, Becton, Dickinson and Company, Singapore, Singapore.

出版信息

Int J Public Health. 2022 May 12;67:1604621. doi: 10.3389/ijph.2022.1604621. eCollection 2022.

DOI:10.3389/ijph.2022.1604621
PMID:35645701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9134213/
Abstract
摘要

相似文献

1
Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?宫颈癌筛查是否到了超越人乳头瘤病毒16型和18型进行基因分型的时候？
Int J Public Health. 2022 May 12;67:1604621. doi: 10.3389/ijph.2022.1604621. eCollection 2022.
2
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.25 岁及以上女性宫颈癌筛查中致癌型人乳头瘤病毒（HPV）检测及 HPV16 或 HPV18 基因分型的性能：ATHENA 研究的一项亚组分析。
Lancet Oncol. 2011 Sep;12(9):880-90. doi: 10.1016/S1470-2045(11)70188-7. Epub 2011 Aug 22.
3
[High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].高危型人乳头瘤病毒基因分型聚合酶链反应检测作为宫颈癌及癌前病变早期筛查手段
Zhonghua Fu Chan Ke Za Zhi. 2015 Apr;50(4):246-52.
4
Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.中国西北地区人乳头瘤病毒 16/18 型感染转诊行阴道镜检查在宫颈癌筛查中的效果评估。
J Med Virol. 2018 Jan;90(1):165-171. doi: 10.1002/jmv.24902. Epub 2017 Oct 17.
5
Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study.HPV16/18 部分基因分型在分层 HPV 阳性接受常规宫颈癌筛查的女性中的临床相关性：一项基于人群的队列研究。
BJOG. 2021 Jul;128(8):1353-1362. doi: 10.1111/1471-0528.16631. Epub 2021 Jan 12.
6
Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.人乳头瘤病毒基因分型与细胞学分流比较，COMPACT 研究：14642 例女性的设计、方法和基线结果。
Cancer Sci. 2018 Jun;109(6):2003-2012. doi: 10.1111/cas.13608. Epub 2018 May 31.
7
Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan.巴基斯坦旁遮普邦宫颈癌样本中高危型人乳头瘤病毒的患病率及基因分型
Viruses. 2014 Jul 17;6(7):2762-77. doi: 10.3390/v6072762.
8
Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.关于雅培实时高危型人乳头瘤病毒检测在宫颈癌筛查中的临床性能的三年纵向数据。
J Clin Virol. 2016 Mar;76 Suppl 1:S29-S39. doi: 10.1016/j.jcv.2015.11.021. Epub 2015 Nov 19.
9
[Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].[人乳头瘤病毒分型检测在子宫颈癌前病变和子宫颈癌筛查中的性能]
Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):252-256. doi: 10.3760/cma.j.cn112152-20190603-00346.
10
The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.人乳头瘤病毒 16/18 型基因分型杂交捕获法在宫颈癌筛查初筛中检测人乳头瘤病毒 DNA 的性能：10669 例中国女性的横断面研究。
Clin Microbiol Infect. 2018 Dec;24(12):1322-1327. doi: 10.1016/j.cmi.2018.02.027. Epub 2018 Mar 5.

引用本文的文献

1
Trends in HPV-positive cervical cancer prevalence: a retrospective study from 2013 to 2020.人乳头瘤病毒（HPV）阳性宫颈癌患病率趋势：一项2013年至2020年的回顾性研究
Virol J. 2025 Jun 18;22(1):199. doi: 10.1186/s12985-025-02830-7.
2
Ad-E6/7-HR vaccine improves the prophylactic and therapeutic efficacy in HPV-associated cancers.腺病毒 E6/E7 重组疫苗可提高人乳头瘤病毒相关癌症的预防和治疗效果。
Clin Transl Med. 2025 Apr;15(4):e70305. doi: 10.1002/ctm2.70305.
3
Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use.人乳头瘤病毒在癌症中的作用：致癌机制与临床应用
Signal Transduct Target Ther. 2025 Jan 24;10(1):44. doi: 10.1038/s41392-024-02083-w.
4
Effectiveness of high-risk human papillomavirus genotyping for cervical cancer screening. A multicentre screening cohort study in rural China.高危型人乳头瘤病毒基因分型用于宫颈癌筛查的效果。中国农村多中心筛查队列研究。
An Sist Sanit Navar. 2024 May 31;47(2):e1065. doi: 10.23938/ASSN.1065.
5
Human Papillomavirus Infections and the Role Played by Cervical and Cervico-Vaginal Microbiota-Evidence from Next-Generation Sequencing Studies.人乳头瘤病毒感染以及宫颈和宫颈阴道微生物群所起的作用——来自新一代测序研究的证据
Cancers (Basel). 2024 Jan 17;16(2):399. doi: 10.3390/cancers16020399.
6
HPV genotyping of cervical histologic specimens of 61, 422 patients from the largest women hospital in China.对来自中国最大的女子医院的61422名患者的宫颈组织学标本进行人乳头瘤病毒基因分型。
Front Oncol. 2023 Mar 29;13:1161631. doi: 10.3389/fonc.2023.1161631. eCollection 2023.
7
Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore.新加坡宫颈癌筛查中HPV全基因分型与部分基因分型的成本效益分析
Cancers (Basel). 2023 Mar 16;15(6):1812. doi: 10.3390/cancers15061812.

本文引用的文献

1
[Global guidelines for cervical cancer screening: a systematic review].[宫颈癌筛查全球指南：一项系统综述]
Zhonghua Yi Xue Za Zhi. 2021 Jun 24;101:1882-1889. doi: 10.3760/cma.j.cn112137-20210115-00134.
2
The Potential Clinical and Economic Value of a Human Papillomavirus Primary Screening Test That Additionally Identifies Genotypes 31, 45, 51, and 52 Individually.一种额外单独鉴定31、45、51和52型基因型的人乳头瘤病毒初筛检测的潜在临床和经济价值
Sex Transm Dis. 2021 May 1;48(5):370-380. doi: 10.1097/OLQ.0000000000001327.
3
Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review.人乳头瘤病毒相同基因型持续性感染与风险：系统评价。
J Low Genit Tract Dis. 2021 Jan 1;25(1):27-37. doi: 10.1097/LGT.0000000000000573.
4
Surveillance systems for monitoring cervical cancer elimination efforts: Focus on HPV infection, cervical dysplasia, cervical screening and treatment.监测宫颈癌消除工作的监测系统：重点关注 HPV 感染、宫颈发育不良、宫颈筛查和治疗。
Prev Med. 2021 Mar;144:106293. doi: 10.1016/j.ypmed.2020.106293. Epub 2020 Oct 17.
5
Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.宫颈癌筛查——低收入国家完整医疗路径面临的挑战：以马拉维为例
Womens Health (Lond). 2020 Jan-Dec;16:1745506520914804. doi: 10.1177/1745506520914804.
6
Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review.人乳头瘤病毒基因分型在宫颈癌筛查中的临床应用：系统评价。
J Low Genit Tract Dis. 2020 Jan;24(1):1-13. doi: 10.1097/LGT.0000000000000494.
7
Human Papillomavirus Genotyping Compared With a Qualitative High-Risk Human Papillomavirus Test After Treatment of High-Grade Cervical Intraepithelial Neoplasia: A Systematic Review.人乳头瘤病毒基因分型与高级别宫颈上皮内瘤变治疗后定性高危型人乳头瘤病毒检测的比较：系统评价。
Obstet Gynecol. 2019 Sep;134(3):452-462. doi: 10.1097/AOG.0000000000003409.
8
The burden of 14 hr-HPV genotypes in women attending routine cervical cancer screening in 20 states of Mexico: a cross-sectional study.14 种 HPV 基因型在墨西哥 20 个州接受常规宫颈癌筛查的女性中的负担：一项横断面研究。
Sci Rep. 2019 Jul 12;9(1):10094. doi: 10.1038/s41598-019-46543-8.
9
Age-specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: A new tool for monitoring vaccine impact.澳大利亚更新后的宫颈癌筛查项目中 116052 名女性的特定年龄 HPV 流行率：监测疫苗效果的新工具。
Vaccine. 2019 Jan 14;37(3):412-416. doi: 10.1016/j.vaccine.2018.11.075. Epub 2018 Dec 11.